Pituitary Development

The Pituitary

Volumn , Issue , 2011, Pages 3-19

  Drouin, Jacques ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882494996     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-380926-1.10001-X     Document Type: Chapter

References (157)

1. Cushing H. The Pituitary Body and Its Disorders 1912, JB Lippincott, Philadelphia.
2. Harris G.W. Neural control of pituitary gland. Physiol Rev 1948, 28:139-179.
3. Harris G.W. The function of the pituitary stalk. Bull. Johns Hopkins Hosp 1955, 97(5):358-375.
4. Guillemin R. Peptides in the brain: The new endocrinology of the neuron. Science 1978, 202(4366):390-402.
5. Couly G.F., Le Douarin N.M. Mapping of the early neural primordium in quail-chick chimeras. I. Developmental relationships between placodes, facial ectoderm, and prosencephalon. Dev Biol 1985, 110:422-439.
6. Couly G.F., Le Douarin N.M. Mapping of the early neural primordium in quail-chick chimeras. II. The prosencephalic neural plate and neural folds: Implications for the genesis of cephalic human congenital abnormalities. Dev Biol 1987, 120:198-214.
7. Daikoku S., Chikamori M., Adachi T., Maki Y. Effect of the basal diencephalon on the development of Rathke's pouch in rats: A study in combined organ cultures. Dev Biol 1982, 90(1):198-202.
8. Watanabe Y.G. Effects of brain and mesenchyme upon the cytogenesis of rat adenohypophysis in vitro. I. Differentiation of adrenocorticotropes. Cell Tissue Res 1982, 227(2):257-266.
9. Kikuyama S., Inaco H., Jenks B.G., Kawamura K. Development of the ectopically transplanted primordium of epithelial hypophysis (anterior neural ridge) in Bufo japonicus embryos. J Exp Zool 1993, 266(3):216-220.
10. Kawamura K., Kikuyama S. Induction from posterior hypothalamus is essential for the development of the pituitary proopiomelacortin (POMC) cells of the toad (Bufo japonicus). Cell Tissue Res 1995, 279(2):233-239.
11. Kimura S., Hara Y., Pineau T., Fernandez-Salguero P., Fox C.H., Ward J.M., et al. The T/ebp null mouse: Thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev 1996, 10:60-69.
12. Zhao Y., Mailloux C.M., Hermesz E., Palkovits M., Westphal H. A role of the LIM-homeobox gene Lhx2 in the regulation of pituitary development. Dev Biol 2010, 337(2):313-323.
13. Takuma N., Sheng H.Z., Furuta Y., Ward J.M., Sharma K., Hogan B.L., et al. Formation of Rathke's pouch requires dual induction from the diencephalon. Development 1998, 125(23):4835-4840.
14. Rizzoti K., Brunelli S., Carmignac D., Thomas P.Q., Robinson I.C., Lovell-Badge R. SOX3 is required during the formation of the hypothalamo-pituitary axis. Nat Genet 2004, 36(3):247-255.
15. Hermesz E., Williams-Simons L., Mahon K.A. A novel inducible element, activated by contact with Rathke's pouch, is present in the regulatory region of the Rpx/Hesx1 homeobox gene. Dev Biol 2003, 260(1):68-78.
16. Charles M.A., Suh H., Drouin J., Camper S.A., Gage P.J. PITX genes are required for cell survival and Lhx3 activation. Mol Endocrinol 2005, 19(7):1893-1903.
17. Lamonerie T., Tremblay J.J., Lanctôt C., Therrien M., Gauthier Y., Drouin J. PTX1, a bicoid-related homeobox transcription factor involved in transcription of pro-opiomelanocortin (POMC) gene. Genes Dev 1996, 10(10):1284-1295.
18. Gage P.J., Suh H., Camper S.A. The bicoid-related Pitx gene family in development. Mamm Genome 1999, 10(2):197-200.
19. Ryan A.K., Blumberg B., Rodriguez-Esteban C., Yonei-Tamura S., Tamura I., Tsukui T., et al. Pitx2 determines left-right asymmetry of internal organs in vertebrates. Nature 1998, 394(6693):545-551.
20. Gage P.J., Suh H.Y., Camper S.A. Dosage requirement of Pitx2 for development of multiple organs. Development 1999, 126(20):4643-4651.
21. Suh H., Gage P.J., Drouin J., Camper S.A. Pitx2 is required at multiple stages of pituitary organogenesis: Pituitary primordium formation and cell specification. Development 2002, 129:329-337.
22. Szeto D.P., Rodriguez-Esteban C., Ryan A.K., O'Connell S.M., Liu F., Kioussi C., et al. Role of the Bicoid-related homeodomain factor Pitx1 in specifying hindlimb morphogenesis and pituitary development. Genes Dev 1999, 13(4):484-494.
23. Lanctôt C., Gauthier Y., Drouin J. Pituitary homeobox 1 (Ptx1) is differentially expressed during pituitary development. Endocrinology 1999, 140(3):1416-1422.
24. Sheng H.Z., Moriyama K., Yamashita T., Li H., Potter S.S., Mahon K.A., et al. Multistep control of pituitary organogenesis. Science 1997, 278(5344):1809-1812.
25. Sheng H.Z., Zhadanov A.B., Mosinger B., Fujii T., Bertuzzi S., Grinberg A., et al. Specification of pituitary cell lineages by the LIM homeobox gene Lhx3. Science 1996, 272(5264):1004-1007.
26. Netchine I., Sobrier M.L., Krude H., Schnabel D., Maghnie M., Marcos E., et al. Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nat Genet 2000, 25(2):182-186.
27. Machinis K., Pantel J., Netchine I., Leger J., Camand O.J., Sobrier M.L., et al. Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. Am J Hum Genet 2001, 69(5):961-968.
28. Sobrier M.L., Attie-Bitach T., Netchine I., Encha-Razavi F., Vekemans M., Amselem S. Pathophysiology of syndromic combined pituitary hormone deficiency due to a LHX3 defect in light of LHX3 and LHX4 expression during early human development. Gene Expr Patterns 2004, 5(2):279-284.
29. Bhangoo A.P., Hunter C.S., Savage J.J., Anhalt H., Pavlakis S., Walvoord E.C., et al. A novel LHX3 mutation presenting as combined pituitary hormonal deficiency. J Clin Endocrinol Metab 2006, 91:747-753.
30. Thomas P.Q., Johnson B.V., Rathjen J., Rathjen P.D. Sequence, genomic organization, and expression of the novel homeobox gene hesx1. J Biol Chem 1995, 270(8):3869-3875.
31. Hermesz E., Mackem S., Mahon K.A. Rpx: A novel anterior-restricted homeobox gene progressively activated in the prechordal plate, anterior neural plate and Rathke's pouch of the mouse embryo. Development 1996, 122(1):41-52.
32. Kawamura K., Kikuyama S. Evidence that hypophysis and hypothalamus constitute a single entity from the primary stage of histogenesis. Development 1992, 115:1-9.
33. Olson L.E., Tollkuhn J., Scafoglio C., Krones A., Zhang J., Ohgi K.A., et al. Homeodomain-mediated beta-catenin-dependent switching events dictate cell-lineage determination. Cell 2006, 125(3):593-605.
34. Dasen J.S., Barbera J.P., Herman T.S., Connell S.O., Olson L., Ju B., et al. Temporal regulation of a paired-like homeodomain repressor/TLE corepressor complex and a related activator is required for pituitary organogenesis. Genes Dev 2001, 15(23):3193-3207.
35. Dattani M.T., Martinez-Barbera J.P., Thomas P.Q., Brickman J.M., Gupta R., Martensson I.L., et al. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 1998, 19(2):125-133.
36. Brinkmeier M.L., Potok M.A., Cha K.B., Gridley T., Stifani S., Meeldijk J., et al. TCF and Groucho-related genes influence pituitary growth and development. Mol Endocrinol 2003, 17(11):2152-2161.
37. Brickman J.M., Clements M., Tyrell R., McNay D., Woods K., Warner J., et al. Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders. Development 2001, 128(24):5189-5199.
38. Dattani M.T., Robinson I.C. The molecular basis for developmental disorders of the pituitary gland in man. Clin Genet 2000, 57(5):337-346.
39. Dattani M.T. Novel insights into the aetiology and pathogenesis of hypopituitarism. Horm Res 2004, 62(Suppl 3):1-13.
40. Sornson M.W., Wu W., Dasen J.S., Flynn S.E., Norman D.J., O'Connell S.M., et al. Pituitary lineage determination by the Prophet-of-Pit-1 homeodomain factor defective in Ames dwarfism. Nature 1996, 384(6607):327-333.
41. Raetzman L.T., Ward R., Camper S.A. Lhx4 and Prop1 are required for cell survival and expansion of the pituitary primordia. Development 2002, 129(18):4229-4239.
42. Ward R.D., Raetzman L.T., Suh H., Stone B.M., Nasonkin I.O., Camper S.A. Role of PROP1 in pituitary gland growth. Mol Endocrinol 2005, 19(3):698-710.
43. Ward R.D., Stone B.M., Raetzman L.T., Camper S.A. Cell proliferation and vascularization in mouse models of pituitary hormone deficiency. Mol Endocrinol 2006, 20(6):1378-1390.
44. Gage P.J., Brinkmeier M.L., Scarlett L.M., Knapp L.T., Camper S.A., Mahon K.A. The ames dwarf gene, df, is required early in pituitary ontogeny for the extinction of rpx transcription and initiation of lineage-specific cell proliferation. Mol Endocrinol 1996, 10(12):1570-1581.
45. Nasonkin I.O., Ward R.D., Raetzman L.T., Seasholtz A.F., Saunders T.L., Gillespie P.J., et al. Pituitary hypoplasia and respiratory distress syndrome in Prop1 knockout mice. Hum Mol Genet 2004, 13(22):2727-2735.
46. Wu W., Cogan J.D., Pfaffle R.W., Dasen J.S., Frisch H., O'Connell S.M., et al. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet 1998, 18(2):147-149.
47. Vallette-Kasic S., Barlier A., Teinturier C., Diaz A., Manavela M., Berthezene F., et al. PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency. J Clin Endocrinol Metab 2001, 86(9):4529-4535.
48. Bottner A., Keller E., Kratzsch J., Stobbe H., Weigel J.F., Keller A., et al. PROP1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: A longitudinal analysis. J Clin Endocrinol Metab 2004, 89(10):5256-5265.
49. Treier M., Gleiberman A.S., O'Connell S.M., Szeto D.P., McMahon J.A., McMahon A.P., et al. Multistep signaling requirements for pituitary organogenesis in vivo. Genes Dev 1998, 12(11):1691-1704.
50. Ericson J., Norlin S., Jessell T.M., Edlund T. Integrated FGF and BMP signaling controls the progression of progenitor cell differentiation and the emergence of pattern in the embryonic anterior pituitary. Development 1998, 125(6):1005-1015.
51. Davis S.W., Camper S.A. Noggin regulates Bmp4 activity during pituitary induction. Dev Biol 2007, 305(1):145-160.
52. Nudi M., Ouimette J.F., Drouin J. Bone morphogenic protein (Smad)-mediated repression of proopiomelanocortin transcription by interference with Pitx/Tpit activity. Mol Endocrinol 2005, 19(5):1329-1342.
53. Treier M., O'Connell S., Gleiberman A., Price J., Szeto D.P., Burgess R., et al. Hedgehog signaling is required for pituitary gland development. Development 2001, 128(3):377-386.
54. Chiang C., Litingtung Y., Lee E., Young K.E., Corden J.L., Westphal H., et al. Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature 1996, 383(6599):407-413.
55. Park H.L., Bai C., Platt K.A., Matise M.P., Beeghly A., Hui C.C., et al. Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation. Development 2000, 127(8):1593-1605.
56. Ohuchi H., Hori Y., Yamasaki M., Harada H., Sekine K., Kato S., et al. FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development. Biochem Biophys Res Commun 2000, 277(3):643-649.
57. De Moerlooze L., Spencer-Dene B., Revest J., Hajihosseini M., Rosewell I., Dickson C. An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development 2000, 127(3):483-492.
58. Brinkmeier M.L., Potok M.A., Davis S.W., Camper S.A. TCF4 deficiency expands ventral diencephalon signaling and increases induction of pituitary progenitors. Dev Biol 2007, 311(2):396-407.
59. Chen J., Hersmus N., Van D.V., Caesens P., Denef C., Vankelecom H. The adult pituitary contains a cell population displaying stem/progenitor cell and early embryonic characteristics. Endocrinology 2005, 146(9):3985-3998.
60. Fauquier T., Rizzoti K., Dattani M., Lovell-Badge R., Robinson I.C. SOX2-expressing progenitor cells generate all of the major cell types in the adult mouse pituitary gland. Proc Natl Acad Sci USA 2008, 105(8):2907-2912.
61. Garcia-Lavandeira M., Quereda V., Flores I., Saez C., Diaz-Rodriguez E., Japon M.A., et al. A GRFa2/Prop1/stem (GPS) cell niche in the pituitary. PLoS ONE 2009, 4(3):e4815.
62. Gleiberman A.S., Michurina T., Encinas J.M., Roig J.L., Krasnov P., Balordi F., et al. Genetic approaches identify adult pituitary stem cells. Proc Nat Acad Sci USA 2008, 105(17):6332-6337.
63. Raetzman L.T., Ross S.A., Cook S., Dunwoodie S.L., Camper S.A., Thomas P.Q. Developmental regulation of Notch signaling genes in the embryonic pituitary: Prop1 deficiency affects Notch2 expression. Dev Biol 2004, 265(2):329-340.
64. Raetzman L.T., Wheeler B.S., Ross S.A., Thomas P.Q., Camper S.A. Persistent expression of Notch2 delays gonadotrope differentiation. Mol Endocrinol 2006, 20(11):2898-2908.
65. Zhu X., Zhang J., Tollkuhn J., Ohsawa R., Bresnick E.H., Guillemot F., et al. Sustained Notch signaling in progenitors is required for sequential emergence of distinct cell lineages during organogenesis. Genes Dev 2006, 20(19):2739-2753.
66. Raetzman L.T., Cai J.X., Camper S.A. Hes1 is required for pituitary growth and melanotrope specification. Dev Biol 2007, 304(2):455-466.
67. Kita A., Imayoshi I., Hojo M., Kitagawa M., Kokubu H., Ohsawa R., et al. Hes1 and Hes5 control the progenitor pool, intermediate lobe specification, and posterior lobe formation in the pituitary development. Mol Endocrinol 2007, 21(6):1458-1466.
68. Monahan P., Rybak S., Raetzman L.T. The notch target gene HES1 regulates cell cycle inhibitor expression in the developing pituitary. Endocrinology 2009, 150(9):4386-4394.
69. Bilodeau S., Roussel-Gervais A., Drouin J. Distinct developmental roles of cell cycle inhibitors p57Kip2 and p27Kip1 distinguish pituitary progenitor cell cycle exit from cell cycle re-entry of differentiated cells. Mol Cell Biol 2009, 29(7):1895-1908.
70. Nolan L.A., Levy A. A population of non-luteinising hormone/non-adrenocorticotrophic hormone-positive cells in the male rat anterior pituitary responds mitotically to both gonadectomy and adrenalectomy. J Neuroendocrinol 2006, 18(9):655-661.
71. Pulichino A.M., Vallette-Kasic S., Tsai J.P.Y., Couture C., Gauthier Y., Drouin J. Tpit determines alternate fates during pituitary cell differentiation. Genes Dev 2003, 17(6):738-747.
72. Gulyas M., Pusztai L., Rappay G., Makara G.B. Pituitary corticotrophs proliferate temporarily after adrenalectomy. Histochemistry 1991, 96(2):185-189.
73. Gregoire D., Kmita M. Recombination between inverted loxP sites is cytotoxic for proliferating cells and provides a simple tool for conditional cell ablation. Proc Nat Acad Sci USA 2008, 105(38):14492-14496.
74. Japon M.A., Rubinstein M., Low M.J. In situ hybridization analysis of anterior pituitary hormone gene expression during fetal mouse development. J Histochem Cytochem 1994, 42:1117-1125.
75. Camper S.A., Saunders T.L., Katz R.W., Reeves R.H. The Pit-1 transcription factor gene is a candidate for the murine snell dwarf mutation. Genomics 1990, 8(3):586-590.
76. Li S., Crenshaw E.B.I., Rawson E.J., Simmons D.M., Swanson L.W., Rosenfeld M.G. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 1990, 347:528-533.
77. Cohen L.E., Radovick S. Molecular basis of combined pituitary hormone deficiencies. Endocr Rev 2002, 23(4):431-442.
78. Fero M.L., Rivkin M., Tasch M., Porter P., Carow C.E., Firpo E., et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 1996, 85(5):733-744.
79. Kiyokawa H., Kineman R.D., Manova-Todorova K.O., Soares V.C., Hoffman E.S., Ono M., et al. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 1996, 85(5):721-732.
80. Nakayama K., Ishida N., Shirane M., Inomata A., Inoue T., Shishido N., et al. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996, 85(5):707-720.
81. Jirawatnotai S., Moons D.S., Stocco C.O., Franks R., Hales D.B., Gibori G., et al. The cyclin-dependent kinase inhibitors p27Kip1 and p21Cip1 cooperate to restrict proliferative life span in differentiating ovarian cells. J Biol Chem 2003, 278(19):17021-17027.
82. Chesnokova V., Zonis S., Kovacs K., Ben Shlomo A., Wawrowsky K., Bannykh S., et al. p21(Cip1) restrains pituitary tumor growth. Proc Nat Acad Sci USA 2008, 105(45):17498-17503.
83. Chesnokova V., Zonis S., Rubinek T., Yu R., Ben Shlomo A., Kovacs K., et al. Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth. Cancer Res 2007, 67(21):10564-10572.
84. Chesnokova V., Melmed S. Pituitary tumour-transforming gene (PTTG) and pituitary senescence. Horm Res 2009, 71(Suppl 2):82-87.
85. Bonnefont X., Lacampagne A., Sanchez-Hormigo A., Fino E., Creff A., Mathieu M.N., et al. Revealing the large-scale network organization of growth hormone-secreting cells. Proc Nat Acad Sci USA 2005, 102(46):16880-16885.
86. Lafont C., Desarmenien M.G., Cassou M., Molino F., Lecoq J., Hodson D., et al. Cellular in vivo imaging reveals coordinated regulation of pituitary microcirculation and GH cell network function. Proc Nat Acad Sci USA 2010, 107(9):4465-4470.
87. Chauvet N., El Yandouzi T., Mathieu M.N., Schlernitzauer A., Galibert E., Lafont C., et al. Characterization of adherens junction protein expression and localization in pituitary cell networks. J Endocrinol 2009, 202(3):375-387.
88. Lamolet B., Pulichino A.M., Lamonerie T., Gauthier Y., Brue T., Enjalbert A., et al. A pituitary cell-restricted T-box factor, Tpit, activates POMC transcription in cooperation with Pitx homeo-proteins. Cell 2001, 104(6):849-859.
89. Pulichino A.M., Vallette-Kasic S., Couture C., Gauthier Y., Brue T., David M., et al. Human and mouse Tpit gene mutations cause early onset pituitary ACTH deficiency. Genes Dev 2003, 17(6):711-716.
90. Vallette-Kasic S., Brue T., Pulichino A.M., Gueydan M., Barlier A., David M., et al. Congenital isolated adrenocorticotropin deficiency: An underestimated cause of neonatal death, explained by TPIT gene mutations. J Clin Endocrinol Metab 2005, 90(3):1323-1331.
91. Vallette-Kasic S., Couture C., Balsalobre A., Gauthier Y., Metherell L.A., Dattani M., et al. The TPIT gene mutation M86R associated with isolated ACTH deficiency interferes in protein:protein interactions. J Clin Endocrinol Metab. 2007, 92(10):3991-3999.
92. Vallette-Kasic S., Figarella-Branger D., Grino M., Pulichino A.M., Dufour H., Grisoli F., et al. Differential regulation of proopiomelanocortin and pituitary-restricted transcription factor (TPIT), a new marker of normal and adenomatous human corticotrophs. J Clin Endocrinol Metab 2003, 88(7):3050-3056.
93. Therrien M., Drouin J. Cell-specific helix-loop-helix factor required for pituitary expression of the pro-opiomelanocortin gene. Mol Cell Biol 1993, 13:2342-2353.
94. Poulin G., Turgeon B., Drouin J. NeuroD1/BETA2 contributes to cell-specific transcription of the POMC gene. Mol Cell Biol 1997, 17(11):6673-6682.
95. Poulin G., Lebel M., Chamberland M., Paradis F.W., Drouin J. Specific protein:protein interaction between basic Helix-Loop-Helix transcription factors and homeoproteins of the Pitx family. Mol Cell Biol 2000, 20:4826-4837.
96. Lavoie P.L., Budry L., Balsalobre A., Drouin J. Developmental Dependence on NurRE and EboxNeuro for Expression of Pituitary POMC. Mol Endocrinol 2008, 22(7):1647-1657.
97. Smith G.W., Aubry J.M., Dellu F., Contarino A., Bilezikjian L.M., Gold L.H., et al. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 1998, 20(6):1093-1102.
98. Bale T.L., Picetti R., Contarino A., Koob G.F., Vale W.W., Lee K.F. Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior. J Neurosci 2002, 22(1):193-199.
99. Lugo D.I., Pintar J.E. Ontogeny of basal and regulated secretion from POMC cells of the developing anterior lobe of the rat pituitary gland. Dev Biol 1996, 173(1):95-109.
100. Lugo D.I., Pintar J.E. Ontogeny of basal and regulated proopiomelanocortin-derived peptide secretion from fetal and neonatal pituitary intermediate lobe cells: Melanotrophs exhibit transient glucocorticoid responses during development. Dev Biol 1996, 173(1):110-118.
101. Heuser I. Anna-Monika-Prize paper. The hypothalamic-pituitary-adrenal system in depression. Pharmacopsychiatry 1998, 31(1):10-13.
102. Holsboer F., Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 1996, 17(2):187-205.
103. Holsboer F., Liebl R., Hofschuster E. Repeated dexamethasone suppression test during depressive illness. Normalisation of test result compared with clinical improvement. J Affect Disord 1982, 4(2):93-101.
104. Nemeroff C.B., Widerlov E., Bissette G., Walleus H., Karlsson I., Eklund K., et al. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 1984, 226(4680):1342-1344.
105. Pace T.W., Hu F., Miller A.H. Cytokine-effects on glucocorticoid receptor function: Relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun 2007, 21(1):9-19.
106. Watson S., Gallagher P., Ferrier I.N., Young A.H. Post-dexamethasone arginine vasopressin levels in patients with severe mood disorders. J Psychiatr Res 2006, 40(4):353-359.
107. Schule C., Baghai T.C., Eser D., Rupprecht R. Hypothalamic-pituitary-adrenocortical system dysregulation and new treatment strategies in depression. Expert Rev Neurother 2009, 9(7):1005-1019.
108. Lamberts S.W.J. Glucocorticoid receptors and Cushing's disease. Mol Cell Endocrinol 2002, 197(1-2):69-72.
109. Bilodeau S., Vallette-Kasic S., Gauthier Y., Figarella-Branger D., Brue T., Berthelet F., et al. Role of Brg1 and HDAC2 in GR trans-repression of pituitary POMC gene and misexpression in Cushing disease. Genes Dev 2006, 20(20):2871-2886.
110. Proulx-Ferland L., Meunier H., Côté J., Dumont D., Gagné B., Labrie F. Multiple factors involved in the control of ACTH and a-MSH secretion. J Steroid Biochem 1983, 19:439-445.
111. Ingraham H.A., Lala D.S., Ikeda Y., Luo X., Shen W.H., Nachtigal M.W., et al. The nuclear receptor steroidogenic factor 1 acts at multiple levels of the reproductive axis. Genes Dev 1994, 8:2302-2312.
112. Ikeda Y., Lala D.S., Luo X., Kim E., Moisan M.P., Parker K.L. Characterization of the mouse FTZ-F1 gene, which encodes a key regulator of steroid hydroxylase gene expression. Mol Endocrinol 1993, 7(7):852-860.
113. Ikeda Y., Shen W.H., Ingraham H.A., Parker K.L. Developmental expression of mouse steroidogenic factor-1, an essential regulator of the steroid hydroxylases. Mol Endocrinol 1994, 8(5):654-662.
114. Luo X., Ikeda Y., Parker K.L. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 1994, 77(4):481-490.
115. Shinoda K., Lei H., Yoshii H., Nomura M., Nagano M., Shiba H., et al. Developmental defects of the ventromedial hypothalamic nucleus and pituitary gonadotroph in the Ftz-F1 disrupted mice. Dev Dyn 1995, 204(1):22-29.
116. Zhao L., Bakke M., Krimkevich Y., Cushman L.J., Parlow A.F., Camper S.A., et al. Steroidogenic factor 1 (SF1) is essential for pituitary gonadotrope function. Development 2001, 128(2):147-154.
117. Ikeda Y., Luo X., Abbud R., Nilson J.H., Parker K.L. The nuclear receptor steroidogenic factor 1 is essential for the formation of the ventromedial hypothalamic nucleus. Mol Endocrinol 1995, 9(4):478-486.
118. Topilko P., Schneider-Maunoury S., Levi G., Trembleau A., Gourdji D., Driancourt M.A., et al. Multiple pituitary and ovarian defects in Krox-24 (NGFI-A, Egr-1)-targeted mice. Mol Endocrinol 1998, 12(1):107-122.
119. Tremblay J.J., Drouin J. Egr-1 is a downstream effector of GnRH and synergizes by direct interaction with Ptx1 and SF-1 to enhance luteinizing hormone b gene transcription. Mol Cell Biol 1999, 19(4):2567-2576.
120. Dorn C., Ou Q., Svaren J., Crawford P.A., Sadovsky Y. Activation of luteinizing hormone beta gene by gonadotropin-releasing hormone requires the synergy of early growth response-1 and steroidogenic factor-1. J Biol Chem 1999, 274(20):13870-13876.
121. Wolfe M.W., Call G.B. Early growth response protein 1 binds to the luteinizing hormone-beta promoter and mediates gonadotropin-releasing hormone-stimulated gene expression. Mol Endocrinol 1999, 13(5):752-763.
122. Charles M.A., Saunders T.L., Wood W.M., Owens K., Parlow A.F., Camper S.A., et al. Pituitary-specific Gata2 knockout: Effects on gonadotrope and thyrotrope function. Mol Endocrinol 2006, 20(6):1366-1377.
123. Dasen J.S., O'Connell S.M., Flynn S.E., Treier M., Gleiberman A.S., et al. Reciprocal interactions of Pit1 and GATA2 mediate signaling gradient-induced determination of pituitary cell types. Cell 1999, 97(5):587-598.
124. Szeto D.P., Ryan A.K., O'Connell S.M., Rosenfeld M.G. P-OTX: A PIT-1-interacting homeodomain factor expressed during anterior pituitary gland development. Proc Nat Acad Sci USA 1996, 93(15):7706-7710.
125. Quirk C.C., Lozada K.L., Keri R.A., Nilson J.H. A single Pitx1 binding site is essential for activity of the LHbeta promoter in transgenic mice. Mol Endocrinol 2001, 15(5):734-746.
126. Zakaria M.M., Jeong K.H., Lacza C., Kaiser U.B. Pituitary homeobox 1 activates the rat FSHbeta (rFSHbeta) gene through both direct and indirect interactions with the rFSHbeta gene promoter. Mol Endocrinol 2002, 16(8):1840-1852.
127. Acampora D., Mazan S., Tuorto F., Avantaggiato V., Tremblay J.J., Lazzaro D., et al. Transient dwarfism and hypogonadism in mice lacking Otx1 reveal prepubescent stage-specific control of pituitary levels of GH. FSH and LH. Development 1998, 125(7):1229-1239.
128. Tajima T., Ohtake A., Hoshino M., Amemiya S., Sasaki N., Ishizu K., et al. OTX2 loss of function mutation causes anophthalmia and combined pituitary hormone deficiency with a small anterior and ectopic posterior pituitary. J Clin Endocrinol Metab 2009, 94(1):314-319.
129. Andersen B., Rosenfeld M.G. POU domain factors in the neuroendocrine system: Lessons from developmental biology provide insights into human disease. Endocr Rev 2001, 22(1):2-35.
130. Bodner M., Castrillo J.L., Theill L.E., Deerinck T., Ellisman M., Karin M. The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein. Cell 1988, 55(3):505-518.
131. Ingraham H.A., Chen R., Mangalam H.J., Elsholtz H.P., Flynn S.E., Lin C.R., et al. A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell 1988, 55(3):519-529.
132. Nica G., Herzog W., Sonntag C., Hammerschmidt M. Zebrafish pit1 mutants lack three pituitary cell types and develop severe dwarfism. Mol Endocrinol 2004, 18(5):1196-1209.
133. Qi Y., Ranish J.A., Zhu X., Krones A., Zhang J., Aebersold R., et al. Atbf1 is required for the Pit1 gene early activation. Proc Nat Acad Sci USA 2008, 105(7):2481-2486.
134. Rhodes S.J., Chen R., DiMattia G.E., Scully K.M., Kalla K.A., Lin S.C., et al. A tissue-specific enhancer confers Pit-1-dependent morphogen inducibility and autoregulation on the pit-1 gene. Genes Dev 1993, 7:913-932.
135. Mullis P.E. Genetic control of growth. Eur J Endocrinol 2005, 152(1):11-31.
136. Day R.N., Koike S., Sakai M., Muramatsu M., Maurer R.A. Both pit-1 and the estrogen receptor are required for estrogen responsiveness of the rat prolactin gene. Mol Endocrinol 1990, 4(12):1964-1971.
137. Crenshaw E.B., Kalla K., Simmons D.M., Swanson L.W., Rosenfeld M.G. Cell-specific expression of the prolactin gene in transgenic mice is controlled by synergistic interactions between promoter and enhancer elements. Genes Dev 1989, 3:959-972.
138. Nowakowski B.E., Maurer R.A. Multiple Pit-1-binding sites facilitate estrogen responsiveness of the prolactin gene. Mol Endocrinol 1994, 8(12):1742-1749.
139. Scully K.M., Gleiberman A.S., Lindzey J., Lubahn D.B., Korach K.S., Rosenfeld M.G. Role of estrogen receptor-alpha in the anterior pituitary gland. Mol Endocrinol 1997, 11(6):674-681.
140. Gutierrez-Hartmann A., Duval D.L., Bradford A.P. ETS transcription factors in endocrine systems. Trends Endocrinol Metab 2007, 18(4):150-158.
141. Bradford A.P., Wasylyk C., Wasylyk B., Gutierrez-Hartmann A. Interaction of Ets-1 and the POU-homeodomain protein GHF-1/Pit-1 reconstitutes pituitary-specific gene expression. Mol Cell Biol 1997, 17(3):1065-1074.
142. Bradford A.P., Conrad K.E., Wasylyk C., Wasylyk B., Gutierrez-Hartmann A. Functional interaction of c-Ets-1 and GHF-1/Pit-1 mediates Ras activation of pituitary-specific gene expression: Mapping of the essential c-Ets-1 domain. Mol Cell Biol 1995, 15(5):2849-2857.
143. Wasylyk B., Hagman J., Gutierrez-Hartmann A. Ets transcription factors: Nuclear effectors of the Ras-MAP-kinase signaling pathway. Trends Biochem Sci 1998, 23(6):213-216.
144. Bradford A.P., Conrad K.E., Tran P.H., Ostrowski M.C., Gutierrez-Hartmann A. GHF-1/Pit-1 functions as a cell-specific integrator of Ras signaling by targeting the Ras pathway to a composite Ets-1/GHF-1 response element. J Biol Chem 1996, 271(40):24639-24648.
145. Schweppe R.E., Melton A.A., Brodsky K.S., Aveline L.D., Resing K.A., Ahn N.G., et al. Purification and mass spectrometric identification of GA-binding protein (GABP) as the functional pituitary Ets factor binding to the basal transcription element of the prolactin promoter. J Biol Chem 2003, 278(19):16863-16872.
146. Tremblay J.J., Lanctôt C., Drouin J. The pan-pituitary activator of transcription, Ptx-1 (pituitary homeobox1), acts in synergy with SF-1 and Pit1 and is an upstream regulator of the Lim-homeodomain gene Lim3/Lhx3. Mol Endocrinol 1998, 12(3):428-441.
147. Tremblay J.J., Goodyer C.G., Drouin J. Transcriptional properties of Ptx1 and Ptx2 isoforms. Neuroendocrinol 2000, 71:277-286.
148. Quentien M.H., Manfroid I., Moncet D., Gunz G., Muller M., Grino M., et al. Pitx factors are involved in basal and hormone-regulated activity of the human prolactin promoter. J Biol Chem 2002, 277(46):44408-44416.
149. Jacob K.K., Stanley F.M. CCAAT/enhancer-binding protein alpha is a physiological regulator of prolactin gene expression. Endocrinology 1999, 140(10):4542-4550.
150. Liu J.C., Baker R.E., Sun C., Sundmark V.C., Elsholtz H.P. Activation of Go-coupled dopamine D2 receptors inhibits ERK1/ERK2 in pituitary cells. A key step in the transcriptional suppression of the prolactin gene. J Biol Chem 2002, 277(39):35819-35825.
151. Saiardi A., Bozzi Y., Baik J.H., Borrelli E. Antiproliferative role of dopamine: Loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia. Neuron 1997, 19(1):115-126.
152. Asa S.L., Kelly M.A., Grandy D.K., Low M.J. Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice. Endocrinology 1999, 140(11):5348-5355.
153. Gordon D.F., Lewis S.R., Haugen B.R., James R.A., Mcdermott M.T., Wood W.M., et al. Pit-1 and GATA-2 interact and functionally cooperate to activate the thyrotropin beta-subunit promoter. J Biol Chem 1997, 272(39):24339-24347.
154. Hashimoto K., Yamada M., Monden T., Satoh T., Wondisford F.E., Mori M. Thyrotropin-releasing hormone (TRH) specific interaction between amino terminus of P-Lim and CREB binding protein (CBP). Mol Cell Endocrinol 2005, 229(1-2):11-20.
155. Hashimoto K., Zanger K., Hollenberg A.N., Cohen L.E., Radovick S., Wondisford F.E. cAMP response element-binding protein-binding protein mediates thyrotropin-releasing hormone signaling on thyrotropin subunit genes. J Biol Chem 2000, 275(43):33365-33372.
156. Sasaki S., Lesoon-Wood L.A., Dey A., Kuwata T., Weintraub B.D., Humphrey G., et al. Ligand-induced recruitment of a histone deacetylase in the negative-feedback regulation of the thyrotropin beta gene. EMBO J 1999, 18(19):5389-5398.
157. Abel E.D., Moura E.G., Ahima R.S., Campos-Barros A., Pazos-Moura C.C., Boers M.E., et al. Dominant inhibition of thyroid hormone action selectively in the pituitary of thyroid hormone receptor-beta null mice abolishes the regulation of thyrotropin by thyroid hormone. Mol Endocrinol 2003, 17(9):1767-1776.